Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118808045 | 11880804 | 5 | F | 201509 | 20160708 | 20151230 | 20160719 | EXP | CA-PFIZER INC-2015329328 | PFIZER | 58.00 | YR | F | Y | 0.00000 | 20160719 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118808045 | 11880804 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | 203214 | 5 | MG | TABLET | BID | ||||||
| 118808045 | 11880804 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 25 MG, WEEKLY | Y | 11719 | 25 | MG | TABLET | /wk | |||||
| 118808045 | 11880804 | 3 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MG, 1X/DAY | Y | 0 | 200 | MG | QD | |||||||
| 118808045 | 11880804 | 4 | C | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 118808045 | 11880804 | 5 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK, EVERY 4 HRS | 0 | |||||||||||
| 118808045 | 11880804 | 6 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118808045 | 11880804 | 1 | Rheumatoid arthritis |
| 118808045 | 11880804 | 2 | Rheumatoid arthritis |
| 118808045 | 11880804 | 3 | Rheumatoid arthritis |
| 118808045 | 11880804 | 4 | Rheumatoid arthritis |
| 118808045 | 11880804 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118808045 | 11880804 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118808045 | 11880804 | Alanine aminotransferase increased | |
| 118808045 | 11880804 | Arthralgia | |
| 118808045 | 11880804 | Aspartate aminotransferase increased | |
| 118808045 | 11880804 | Diarrhoea | |
| 118808045 | 11880804 | Drug effect incomplete | |
| 118808045 | 11880804 | Haemorrhage | |
| 118808045 | 11880804 | Herpes zoster | |
| 118808045 | 11880804 | Hypoaesthesia | |
| 118808045 | 11880804 | Joint lock | |
| 118808045 | 11880804 | Mobility decreased | |
| 118808045 | 11880804 | Skin lesion | |
| 118808045 | 11880804 | Tuberculin test positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118808045 | 11880804 | 1 | 20151118 | 0 | ||
| 118808045 | 11880804 | 2 | 201406 | 20160425 | 0 | |
| 118808045 | 11880804 | 3 | 201503 | 0 |